key: cord-0863935-ukhmihrx authors: An, Ping; Huang, Xu; Wan, Xinyue; Xiao, Yong; Zhang, Jun; Kang, Jian; Liu, Jun; Hu, Dan; Wang, Yang; Ren, Haixia; Chen, Di; Wang, Xuefen; Zhou, Zhongyin; Yu, Honggang title: ERCP during the pandemic of COVID-19 in Wuhan, China date: 2020-04-16 journal: Gastrointest Endosc DOI: 10.1016/j.gie.2020.04.022 sha: 65950cc4007340c648fe3698e3400bdbf5dc2206 doc_id: 863935 cord_uid: ukhmihrx nan We read with great interest the recent articles by Repici et al 1 and Soetikno et al. 2 An outbreak of a novel coronavirus pneumonia has rapidly spread through the whole country and is now a worldwide pandemic. Up to March 30, the National Health and Health Commission of China has reported a total of 82,423 confirmed cases in 31 provinces, 3306 cases of deaths, and total 615,699 confirmed cases worldwide. 3 With the development of the pandemic, more countries have become involved in this serious battle against the virus. ERCP is an important and effective procedure of choice for biliary decompression. Despite the highly infectious danger in COVID-19 outbreak areas, ERCP is still required for patients with emergent biliary obstruction and for those who cannot wait until the next available elective list. Direct contact, airborne droplets and touch contamination, and uncertain fecal-oral transmission greatly increase the infection risk of ERCP procedures. 4 To guarantee the safety of healthcare workers and patients for ERCP procedures, we established infection prevention measures and standard operating procedures in our endoscopy center of gastroenterology department to guarantee a safe environment to protect both patients and healthcare personnel. Here, we retrospectively reviewed ERCP procedures in 31 patients during the pandemic of COVID-19 to evaluate the safety and essential protection measures. Patients with acute obstructive cholangitis, aggravated bile duct obstruction (rapid increased serum total bilirubin [TBIL]), acute biliary pancreatitis, and common bile duct (CBD) gallstones with fever, abdominal pain, and jaundice received ERCPs during the outbreak. COVID-19 screening examinations including chest CT scans, complete blood tests, virological nuclei acid PCR tests (nasal and oropharyngeal swab samples), and COVID-19 IgM/IgG were mandatory for all patients and the people accompanying those patients before ERCP, except for emergent 3 cases. COVID-19 patients were admitted in designated wards. Other patients negative to COVID-19 infection spent 6 days of observation and preparation to transfer from 2 buffer zone wards (with 3 days of observation per ward) to GI department wards. COVID-19-related symptoms including fever, cough, chest pain, and dyspnea were kept under observation during the whole hospitalization, and COVID-19 screenings were considered once these alert symptoms were presented. The study protocol was approved by the ethics committee of Renmin Hospital of Wuhan University, and waiver of informed consent was obtained (ID: WDRY2020-K075). All ERCPs were performed with the patient under conscious sedation with propofol and pethidine, and the patient was monitored by an anesthesiologist or endoscopist during the procedures. After ERCPs, COVID-19 patients returned to designated wards, and uninfected patients were admitted back to the buffer zone or GI wards for further treatments and observations. and typical symptoms regarding fever, cough, breathlessness, and diarrhea. Personal protective equipment (PPE) were suggested to be provided accordingly. 5 However, given that atypical symptoms without fever and respiratory presentations and current community transmission from asymptomatic patients with COVID-19 have already been documented (and false-negative results of virological test in some cases), it is challenging to identify all COVID-19 patients before ERCP procedures. Furthermore, for patients who needed urgent ERCP, fever, abdominal pain, anorexia, and diarrhea were common seen and greatly increased the complexity of differentiation. Therefore, in the standard operating procedure of our ERCP team, we regarded 5 all new patients as potential COVID-19 candidates regardless of whether the patients were considered low or high risk for COVID-19. Although all patients were asked to screen for COVID-19 before ERCP, some emergent cases could not wait for the results. In these emergent cases, samples were taken for virus screening right before the procedure. It is important to differentiate community infection from nosocomial infection of the virus. One COVID-19 patient was confirmed in the first buffer zone ward after the ERCP procedure and was confirmed as having a community infection. Our measurements successfully identified this infected patient and prevented risky transmission. By the date of this article submission, no other patients, accompanying people, or medical workers in our endoscopic center were reported and diagnosed as having the COVID-19 infection. In conclusion, our measures guaranteed that all healthcare workers in our endoscopy center, patients, and accompanying persons would avoid COVID-19 infection and successfully identified a virus-infected case during the procedure. Our experiences and measures for ERCP would help others to establish optimal measures or standard operating procedures to avoid further unrecognized spread of the disease. COVID-19) outbreak: what the department of endoscopy should know Considerations in performing endoscopy during the COVID-19 pandemic The National Health and Health Commission of China Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) -Update European Centre for Disease Prevention and Control. Personal protective equipment (PPE) needs in healthcare settings for the care of patients with suspected or confirmed novel coronavirus (2019-nCoV) 2020 This work was partly supported by the grant from the National Natural Science Foundation of